Superworth

Alignment Healthcare ALHC

Medical - Healthcare Plans, Healthcare
$7.00
−3.71%
Market cap
$1.5B
PE
53.8×
Forward PE
n/m
not a meaningful number
Price to sales
0.3×
EV/EBIT
19.8×
Revenue, 12 months
$4.9B
+36% on a year ago
Net margin
0.6%
Free cash flow yield
5.3%

Alignment Healthcare trades at 53.8× trailing earnings. Revenue was $4.9B over the last twelve months, up 36% on a year earlier with a 1% net margin.

Charts

Financials

Income statement for ALHC, by quarter
Income statementQ4 FY23Q1 FY24Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26
$465.4M+29%$628.6M+43%$681.3M+47%$692.4M+52%$701.2M+51%$926.9M+48%$1B+49%$993.7M+44%$1B+44%$1.2B+33%$1.3B+32%$1.4B+37%
SG&A$83.7M+1%$90.5M+29%$87.9M+25%$90.9M+9%$102.1M+22%$103.8M+15%$103.8M+18%$110M+21%$125.8M+23%$121.1M+17%$131M+26%$136.4M+24%
−$41.9M−20%−$41.1M+27%−$18.4M−22%−$19.5M−34%−$22.5M−46%−$5.4M−87%$22.7M$7.7M−$10.3M−54%$15.5M$42.1M+85%−$3.8M
Interest expense$5.5M+14%$5.4M+8%$5.7M+8%$6.9M+27%$5.5M+0%$4M−27%$4M−31%$4M−43%$3.9M−28%$4.1M+3%$4.3M+8%$4.3M+8%
Pre-tax income−$47.3M−17%−$46.6M+25%−$24M−16%−$26.4M−25%−$31.1M−34%−$9.3M−80%$18.9M$3.7M−$14.2M−54%$11.4M$37.8M+100%−$8.1M
−$24K$0$22K+2100%−$8K$7K$21K$3.2M+14555%$2K−$3.2M$25K+19%$1.3M−61%−$22K
Net income−$47.2M−17%−$46.5M+25%−$24M−16%−$26.4M−25%−$31.1M−34%−$9.1M−80%$15.7M$3.7M−$11M−65%$11.4M$36.6M+133%−$8.1M
−$0.25−$0.25+25%−$0.13−13%−$0.14−26%−$0.16−36%−$0.05−80%$0.07$0.02−$0.05−69%$0.05$0.17+143%−$0.04
188.4M189M+3%190.9M+3%191.4M+2%191.9M+2%193.6M+2%209.5M+10%208.9M+9%201M+5%213.1M+10%215M+3%208.6M−0%

EPS, diluted: 4 periods, Q4 FY21 to Q4 FY25: quarter's net income to common over its shares, to the cent.

Diluted shares: Q2 FY21 and Q3 FY21: a loss quarter: its basic count, printed 3 months. 4 periods, Q4 FY21 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q2 FY22: a loss quarter: its basic count, share-days: the 6-month average less the 3-month, weighted by days.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Peers

Companies in Healthcare nearest Alignment Healthcare's size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
ALHCAlignment Healthcare$1.5B53.8×76.9×0.3×+36%0.6%
PCRXPacira BioSciences$1.5B104×65.7×1.9×+6%2.0%
PNTGPennant$1.4B45.0×46.5×1.3×+38%2.9%
ANABAnaptysbio$1.4B10.3×99.3×n/mn/mn/m
HLFHerbalife$1.4B8.6×10.3×0.3×+6%3.2%
CNMDCONMED$1.4B19.3×52.9×1.0×+2%5.4%
PAHCPhibro Animal Health$1.6B15.9×21.5×1.0×+17%6.6%
EYENational Vision$1.4B28.1×52.7×0.7×+8%2.5%
CDRECadre$1.3B38.9×35.9×2.0×+20%5.3%
TRUPTrupanion$1.3B58.0×58.8×0.9×+12%1.5%
ANIPANI Pharmaceuticals$1.6B15.0×57.5×1.7×+31%11.1%
Peer median$1.4B23.7×52.8×1.0×+12%3.2%

More on Alignment Healthcare

Each number over time

Where it ranks

Its groups

About

Industry
Medical - Healthcare Plans
Sector
Healthcare

Valuation data, not investment advice. Prices as of .